Outlook on the Worldwide Clinical In Vitro Diagnostic Medical Laboratory Services Industry to 2024 - Situation Analysis and Executive & Consultant Guides - ResearchAndMarkets.com

The "Global Clinical In Vitro Diagnostic Medical Laboratory Services Market. Strategies & Trends. Volume & Price. Updated with Impact of COVID-19 Pandemic. Situation Analysis and Executive & Consultant Guides. 2020 to 2024" report has been added to ResearchAndMarkets.com's offering.

The Clinical Laboratory has seen steady growth for the last 20 years, but this is changing with the effect of the COVID pandemic on healthcare and economic activity. Worse still, Point of Care and Self Testing are threatening long term demand. Understand the opportunities and the threats in this comprehensive report.

The fundamentals are still here. Clinical laboratory testing is positioned to directly benefit from the explosion in biotechnology, especially genomics. Learn all about it in this new report from Howe Sound Research. A range of dynamic trends are pushing market growth and company valuations.

Trends like:

• the genetic blizzard
• emerging economies and global prosperity
• pharmacogenomics
• healthcare expansion in China
• climate change
• globalization
• automation

Exciting technical developments, especially in the area of molecular diagnostics and pharmacogenomics, hold the promise of a dynamic, growing and evolving world market that is moving out of the national and regional orientation and onto a global stage.

The report provides data that analysts and planners can use. Hundreds of pages of information including a complete list of Current 2020 United States Medicare Fee Payment Schedules to help sharpen your pricing. Make facilities planning decisions. Forecast demand for new testing regimes or technologies. Make research investment decisions.

The report includes detailed breakouts for 15 Countries and 4 Regions. A detailed breakout for any country in the world is available to purchasers of the report.

Key Topics Covered:

1. Introduction and Market Definition

2. Overview of a Dynamic Market

3. Trends Driving a Changing Market

3.1 Growth is Pushed from Many Sides

3.2 Factors at Work to Shrink the Market.

3.3 Automation

3.4 Environment and Evolution

3.5 Diagnostic Technology Development

4. Laboratory, Molecular Diagnostics and Genomic Testing Recent Developments

4.1 Recent Developments - Importance and How to Use This Section

4.1.1 Importance of These Developments

4.1.2 How to Use This Section

5. Country Market Sizes - North America 2016 to 2024

5.1 United States of America 2016 to 2024

5.1.1 Clinical Chemistry - Volumes, Prices, Revenues

5.1.2 Microbiology - Volumes, Prices, Revenues

5.1.3 Hematology - Volumes, Prices, Revenues

5.1.4 Anatomic Pathology - Volumes, Prices, Revenues

5.1.5 Molecular Diagnostics - Volumes, Prices, Revenues

5.1.6 All Clinical Testing - Volumes, Prices, Revenues

5.1.7 Esoteric - Volumes, Prices, Revenues

5.2 Canada 2016 to 2024

5.2.1 Clinical Chemistry - Volumes, Prices, Revenues

5.2.2 Microbiology - Volumes, Prices, Revenues

5.2.3 Hematology - Volumes, Prices, Revenues

5.2.4 Anatomic Pathology - Volumes, Prices, Revenues

5.2.5 Molecular Diagnostics - Volumes, Prices, Revenues

5.2.6 All Clinical Testing - Volumes, Prices, Revenues

5.2.7 Esoteric - Volumes, Prices, Revenues

6. Country Markets - Europe 2016 to 2024

7. Country Markets - Asia Pacific 2016 to 2024

8. Country Markets - Latin America, Africa & the Middle East 2016 to 2024

9. Global Market Summary 2016 to 2024

9.1 Global Market 2016 to 2024

9.1.1 Clinical Chemistry - Volumes, Prices, Revenues

9.1.2 Microbiology - Volumes, Prices, Revenues

9.1.3 Hematology - Volumes, Prices, Revenues

9.1.4 Anatomic Pathology - Volumes, Prices, Revenues

9.1.5 Molecular Diagnostics - Volumes, Prices, Revenues

9.1.6 All Clinical Testing - Volumes, Prices, Revenues

9.1.7 Esoteric - Volumes, Prices, Revenues

10. The Future of the Clinical Laboratory

11. Additional Country Breakouts McKinsey

11.1 Switzerland 2016 to 2024

11.1.1 Clinical Chemistry - Volumes, Prices, Revenues

11.1.2 Microbiology - Volumes, Prices, Revenues

11.1.3 Hematology - Volumes, Prices, Revenues

11.1.4 Anatomic Pathology - Volumes, Prices, Revenues

11.1.5 Molecular Diagnostics - Volumes, Prices, Revenues

11.1.6 All Clinical Testing - Volumes, Prices, Revenues

11.1.7 Esoteric - Volumes, Prices, Revenues

11.2 Portugal 2016 to 2024

11.3 Norway 2016 to 2024

11.4 Sweden 2016 to 2024

11.5 Benelux 2016 to 2024

Companies Mentioned

• Acibadem Labmed Laboratory
• ACM Medical Laboratory
• Adicon Clinical Laboratories
• American Bio-Clinical Laboratories, Int'l.
• American Pathology Partners
• ARUP Laboratories
• Ascend Clinical
• Aurora Diagnostics
• Bio-Reference Laboratories
• Bioscientia Institut fr Medizinische Diagnostik GmbH
• BP Healthcare Group.
• Clinical Reference Laboratory
• Clongen Laboratories
• CompuNet Clinical Laboratories
• Diagnosticos da America
• DIAN Diagnostics Co., Ltd
• Enzo Life Sciences, Inc.
• Eurofins Scientific
• Exagen Diagnostics
• Genomic Health
• Genzyme Corporation
• Gribbles Pathology
• Guangzhou Kingmed Diagnostics Group Co., Ltd
• Integrated Regional Laboratories
• KDL Group.
• Laboratory Corporation of America
• Lifelabs
• Mayo Clinic Laboratories
• Mid America Clinical Laboratories
• Myriad Genetics/Myriad RBM
• NeoGenomics
• Pathology, Inc.
• Psychemedics Corporation
• Quest Diagnostics
• RDL Reference Laboratory
• Sonic Healthcare
• Spectra Laboratories
• Synlab Group
• Unilabs

For more information about this report visit https://www.researchandmarkets.com/r/ire1ku

View source version on businesswire.com: https://www.businesswire.com/news/home/20200424005174/en/